3 buy-and-forget FTSE 100 stocks yielding 5%+

Looking for blue-chip income? These FTSE 100 (INDEXFTSE: UKX) stocks could revolutionise your portfolio, says Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There are plenty of blue-chip stocks in the UK that yield more than 5% right now. Today, I’m going to cover three of my favourites. If you are looking for income, I highly recommend taking a closer look at these FTSE 100 dividend stocks.

Revving higher

There’s a reason why Warren Buffett has invested most of his money in insurance companies, and that’s because they tend to be highly profitable. Direct Line (LSE: DLG) is no exception.

One of the UK’s leading insurance businesses, Direct Line sells its insurance policies direct to customers so, unlike many of its peers, the group doesn’t have to pay hefty commission fees to brokers. This clearly shows in the company’s profit margins. Last year, the firm reported an operating profit margin of 16.9%, compared to the UK insurance industry average of 8.5%.

City analysts believe the company will distribute 28.5p per share in dividends this year, giving a potential dividend yield of 8.4%. Last year it paid out 21p and in 2017 it distributed 20.4p.

In other words, Direct Line has a history of distributing lots of capital to shareholders. Unless the company’s business suffers a sudden shock, I don’t see any reason why this trend will not continue. At the time of writing, the shares are dealing at a forward P/E of just 11.4.

Under the radar

My second blue-chip income play is Phoenix Group (LSE: PHNX). Phoenix isn’t a household name, and it isn’t likely to become one anytime soon. The company specialises in the acquisition and management of closed life insurance and pension funds, which is hardly the most exciting sector.

The business of managing pension assets might be boring, but it’s essential and Phoenix has carved out a niche for itself in the industry. After buying Standard Life Aberdeen’s insurance business last year, profits at the group jumped nearly 100% in 2018 to £708m, and assets under administration hit £226bn.

Off the back of this growth, management decided to increase the company’s dividend to 46p, giving the shares a yield of 6.3% at current prices. City analysts are expecting more of the same for the next two years with the payout set to increase marginally to 46.8p by 2020.

The shares do look expensive, trading at a forward P/E of 18. But the stock is also trading at a discount to book value of 10% so, from this perspective, Phoenix looks undervalued at current levels.

Turnaround complete

Sticking with the insurance theme, RSA Insurance (LSE: RSA) is my third and final blue-chip income play I’m going to profile.

After cutting its dividend by 70% in 2013, and then 80% in 2014 as losses mounted, the team at RSA has been working flat out to turn the business around. Led by former RBS boss Stephen Hester, the company is now back on firm ground. Profits have recovered and the dividend is growing rapidly.

This year, the City expects the company to report a net profit of £488m and earnings per share of 45.5p. Analysts believe this will give the business capacity to distribute 28.7p per share to investors, giving a dividend yield of 5.4% at the time of writing. They’ve also pencilled in dividend growth of 13% for 2020, offering a potential dividend yield of 6.1% for next year.

Shares in RSA are currently changing hands at a forward P/E of 10.9.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns shares in Standard Life. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »